Global Embolization Particle Competitive Landscape Professional Research Report 2025

Global Embolization Particle Competitive Landscape Professional Research Report 2025



Research Summary

Embolization particles, also known as embolic agents, are tiny materials used in medical procedures to block or occlude blood vessels or arteries. They are typically administered to manage various medical conditions, such as controlling bleeding, treating vascular malformations, or blocking the blood supply to tumors. These particles can be made of different materials, such as gelatin foam, microspheres, or coils, and are chosen based on the specific medical purpose. When introduced into the targeted blood vessel, embolization particles create a blockage, restricting or completely cutting off blood flow. This technique is employed to treat various medical conditions, often minimizing the need for more invasive surgeries and reducing the risk of complications.

According to DIResearch's in-depth investigation and research, the global Embolization Particle market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Embolization Particle include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, INterface BIOmaterials B.V., HENGRUI Medical, Alicon etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Embolization Particle. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Embolization Particle market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Embolization Particle market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Embolization Particle industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Embolization Particle Include:

Sirtex Medical

Merit Medical

Cook Medical

BTG Medical

Boston Scientific Corporation

Terumo Corporation

INterface BIOmaterials B.V.

HENGRUI Medical

Alicon

Embolization Particle Product Segment Include:

Microspheres

Particles (e.g. PVA Particles, Gelfoam Particles)

Drug-eluting Beads (DEBs)

Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

Embolization Particle Product Application Include:

Uterine Fibroid Embolization

Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

Liver Tumor Embolization

Trauma Embolization

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Embolization Particle Industry PESTEL Analysis

Chapter 3: Global Embolization Particle Industry Porter’s Five Forces Analysis

Chapter 4: Global Embolization Particle Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Embolization Particle Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Embolization Particle Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Embolization Particle Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Embolization Particle Market Overview
1.1 Product Definition and Statistical Scope
1.2 Embolization Particle Product by Type
1.2.1 Microspheres
1.2.2 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.3 Drug-eluting Beads (DEBs)
1.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle Product by Application
1.3.1 Uterine Fibroid Embolization
1.3.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.3 Liver Tumor Embolization
1.3.4 Trauma Embolization
1.3.5 Others
1.4 Global Embolization Particle Market Revenue and Sales Analysis
1.4.1 Global Embolization Particle Revenue Market Size Analysis (2020-2032)
1.4.2 Global Embolization Particle Sales Market Size Analysis (2020-2032)
1.4.3 Global Embolization Particle Market Sales Price Trend Analysis (2020-2032)
1.5 Embolization Particle Industry Trends and Innovation
1.5.1 Embolization Particle Industry Trends and Innovation
1.5.2 Embolization Particle Market Drivers and Challenges
2 Embolization Particle Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Embolization Particle Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Embolization Particle Market Analysis by Regions
4.1 Embolization Particle Overall Market: 2024 VS 2025 VS 2032
4.2 Global Embolization Particle Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Embolization Particle Revenue and Market Share by Region (2020-2025)
4.2.2 Global Embolization Particle Revenue and Market Share Forecast by Region (2026-2032)
4.3 Global Embolization Particle Sales and Forecast Analysis (2020-2032)
4.3.1 Global Embolization Particle Sales and Market Share by Region (2020-2025)
4.3.2 Global Embolization Particle Sales Forecast by Region (2026-2032)
4.4 Global Embolization Particle Sales Price Trend Analysis (2020-2032)
5 Global Embolization Particle Market Size by Type and Application
5.1 Global Embolization Particle Market Size by Type
5.1.1 Global Embolization Particle Revenue and Forecast Analysis by Type (2020-2032)
5.1.2 Global Embolization Particle Sales and Forecast Analysis by Type (2020-2032)
5.2 Global Embolization Particle Market Size by Application
5.2.1 Global Embolization Particle Revenue and Forecast Analysis by Application (2020-2032)
5.2.2 Global Embolization Particle Sales and Forecast Analysis by Application (2020-2032)
6 North America
6.1 North America Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Embolization Particle Market Size by Type
6.3.1 North America Embolization Particle Sales by Type (2020-2032)
6.3.2 North America Embolization Particle Revenue by Type (2020-2032)
6.4 North America Embolization Particle Market Size by Application
6.4.1 North America Embolization Particle Sales by Application (2020-2032)
6.4.2 North America Embolization Particle Revenue by Application (2020-2032)
6.5 North America Embolization Particle Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Embolization Particle Market Size by Type
7.3.1 Europe Embolization Particle Sales by Type (2020-2032)
7.3.2 Europe Embolization Particle Revenue by Type (2020-2032)
7.4 Europe Embolization Particle Market Size by Application
7.4.1 Europe Embolization Particle Sales by Application (2020-2032)
7.4.2 Europe Embolization Particle Revenue by Application (2020-2032)
7.5 Europe Embolization Particle Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Embolization Particle Market Size by Type
8.3.1 China Embolization Particle Sales by Type (2020-2032)
8.3.2 China Embolization Particle Revenue by Type (2020-2032)
8.4 China Embolization Particle Market Size by Application
8.4.1 China Embolization Particle Sales by Application (2020-2032)
8.4.2 China Embolization Particle Revenue by Application (2020-2032)
9 APAC (excl. China)
9.1 APAC (excl. China) Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Embolization Particle Market Size by Type
9.3.1 APAC (excl. China) Embolization Particle Sales by Type (2020-2032)
9.3.2 APAC (excl. China) Embolization Particle Revenue by Type (2020-2032)
9.4 APAC (excl. China) Embolization Particle Market Size by Application
9.4.1 APAC (excl. China) Embolization Particle Sales by Application (2020-2032)
9.4.2 APAC (excl. China) Embolization Particle Revenue by Application (2020-2032)
9.5 APAC (excl. China) Embolization Particle Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Embolization Particle Market Size by Type
10.3.1 Latin America Embolization Particle Sales by Type (2020-2032)
10.3.2 Latin America Embolization Particle Revenue by Type (2020-2032)
10.4 Latin America Embolization Particle Market Size by Application
10.4.1 Latin America Embolization Particle Sales by Application (2020-2032)
10.4.2 Latin America Embolization Particle Revenue by Application (2020-2032)
10.5 Latin America Embolization Particle Market Size by Country
10.6 Latin America Embolization Particle Market Size by Country
10.6.1 Mexico
10.6.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Embolization Particle Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Embolization Particle Market Size by Type
11.3.1 Middle East & Africa Embolization Particle Sales by Type (2020-2032)
11.3.2 Middle East & Africa Embolization Particle Revenue by Type (2020-2032)
11.4 Middle East & Africa Embolization Particle Market Size by Application
11.4.1 Middle East & Africa Embolization Particle Sales by Application (2020-2032)
11.4.2 Middle East & Africa Embolization Particle Revenue by Application (2020-2032)
11.5 Middle East Embolization Particle Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Embolization Particle Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
12.1.1 Global Embolization Particle Market Sales by Key Manufacturers (2021-2025)
12.1.2 Global Embolization Particle Market Revenue by Key Manufacturers (2021-2025)
12.1.3 Global Embolization Particle Average Sales Price by Manufacturers (2021-2025)
12.2 Embolization Particle Competitive Landscape Analysis and Market Dynamic
12.2.1 Embolization Particle Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Sirtex Medical
13.1.1 Sirtex Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Sirtex Medical Embolization Particle Product Portfolio
13.1.3 Sirtex Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.2 Merit Medical
13.2.1 Merit Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Merit Medical Embolization Particle Product Portfolio
13.2.3 Merit Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.3 Cook Medical
13.3.1 Cook Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Cook Medical Embolization Particle Product Portfolio
13.3.3 Cook Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.4 BTG Medical
13.4.1 BTG Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 BTG Medical Embolization Particle Product Portfolio
13.4.3 BTG Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.5 Boston Scientific Corporation
13.5.1 Boston Scientific Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Boston Scientific Corporation Embolization Particle Product Portfolio
13.5.3 Boston Scientific Corporation Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.6 Terumo Corporation
13.6.1 Terumo Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Terumo Corporation Embolization Particle Product Portfolio
13.6.3 Terumo Corporation Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.7 INterface BIOmaterials B.V.
13.7.1 INterface BIOmaterials B.V. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
13.7.3 INterface BIOmaterials B.V. Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.8 HENGRUI Medical
13.8.1 HENGRUI Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 HENGRUI Medical Embolization Particle Product Portfolio
13.8.3 HENGRUI Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
13.9 Alicon
13.9.1 Alicon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Alicon Embolization Particle Product Portfolio
13.9.3 Alicon Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Embolization Particle Industry Chain Analysis
14.2 Embolization Particle Industry Raw Material and Suppliers Analysis
14.2.1 Embolization Particle Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Embolization Particle Typical Downstream Customers
14.4 Embolization Particle Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings